Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

RUSSO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.913
EU - Europa 12.313
AS - Asia 2.957
SA - Sud America 54
AF - Africa 30
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 27
Totale 52.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.858
IT - Italia 3.328
FI - Finlandia 2.255
CN - Cina 2.225
DE - Germania 1.591
UA - Ucraina 1.350
RU - Federazione Russa 883
GB - Regno Unito 763
IE - Irlanda 734
SE - Svezia 499
FR - Francia 205
RO - Romania 191
BE - Belgio 188
IN - India 154
KR - Corea 145
TR - Turchia 93
IR - Iran 81
NL - Olanda 66
PL - Polonia 44
HK - Hong Kong 41
CA - Canada 39
CH - Svizzera 38
ES - Italia 37
JP - Giappone 37
AT - Austria 30
GR - Grecia 28
EU - Europa 23
AU - Australia 22
BR - Brasile 22
EG - Egitto 21
SG - Singapore 20
PK - Pakistan 19
UZ - Uzbekistan 18
TW - Taiwan 17
CZ - Repubblica Ceca 16
LB - Libano 16
BG - Bulgaria 15
MX - Messico 14
CL - Cile 10
IL - Israele 9
DK - Danimarca 8
ID - Indonesia 8
MY - Malesia 8
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
PE - Perù 7
SA - Arabia Saudita 7
VN - Vietnam 7
AR - Argentina 6
BD - Bangladesh 6
KZ - Kazakistan 6
NO - Norvegia 6
HU - Ungheria 5
PH - Filippine 5
PT - Portogallo 5
ZA - Sudafrica 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CY - Cipro 4
TH - Thailandia 4
AL - Albania 3
CO - Colombia 3
EC - Ecuador 3
HR - Croazia 3
KW - Kuwait 3
LT - Lituania 3
MK - Macedonia 3
AM - Armenia 2
BY - Bielorussia 2
EE - Estonia 2
IM - Isola di Man 2
IQ - Iraq 2
KH - Cambogia 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
UG - Uganda 1
UY - Uruguay 1
VE - Venezuela 1
Totale 52.324
Salva come PNG Salva come JPEG
Città #
Fairfield 6.499
Ashburn 3.570
Woodbridge 3.305
Chandler 2.839
Houston 2.708
Wilmington 2.580
Seattle 2.510
Cambridge 2.120
Ann Arbor 1.968
Palermo 783
Medford 774
Dublin 724
Jacksonville 694
Des Moines 565
Altamura 536
Nanjing 531
Princeton 497
Lawrence 416
San Diego 376
Dearborn 332
New York 326
Boardman 255
Ludwigshafen am Rhein 234
Tulsa 223
Beijing 221
Brussels 183
London 169
Shenyang 167
Nanchang 151
Jinan 141
Phoenix 135
Changsha 130
Hebei 126
Seongnam 123
Milan 120
Jiaxing 107
Tianjin 103
Bremen 93
Helsinki 91
Falls Church 90
San Paolo di Civitate 87
Kumar 86
Saint Petersburg 86
Izmir 81
Venice 78
Ningbo 77
Redwood City 68
Zhengzhou 67
Rome 62
Los Angeles 58
Tehran 55
Guangzhou 51
San Mateo 48
Kilburn 45
Verona 45
Norwalk 41
Chicago 39
Pune 39
Auburn Hills 38
Hangzhou 38
Taizhou 38
Orange 35
Taiyuan 34
Munich 32
Washington 29
Kunming 28
Tappahannock 25
Haikou 24
Lanzhou 24
Moscow 24
Fuzhou 22
Kraków 22
Redmond 19
Amsterdam 18
Edinburgh 18
Central 17
Düsseldorf 16
Hanover 16
Toronto 16
Atlanta 15
Hefei 15
Hounslow 14
Tokyo 14
Wandsworth 14
Madrid 13
San Francisco 13
Chiswick 12
Islington 12
Aversa 11
Bologna 11
Frankfurt am Main 11
Lancaster 11
Padova 11
Singapore 11
Stockholm 11
Turin 11
Vienna 11
Athens 10
Groningen 10
Hong Kong 10
Totale 39.412
Salva come PNG Salva come JPEG
Nome #
S9-Fibronectin, EGF-R, HB-EGF:biomarkers of urothelial damage during intravesical adjuvant therapy? 509
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 276
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 260
EGFR inhibition in NSCLC: New findings…. and opened questions? 247
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 215
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 207
Dietary restriction: could it be considered as speed bump on tumor progression road? 205
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 198
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 196
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 193
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 192
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 191
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 191
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 189
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 188
Founder mutations in BRCA1 and BRCA2 genes 188
Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. 188
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 187
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 186
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 185
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 185
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 184
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 183
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 182
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 180
Liquid Biopsy in Breast Cancer 179
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 179
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 177
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 177
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 177
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 174
EGFR genomic alterations in cancer: prognostic and predictive values 174
Apoptosis: a relevant tool for anticancer therapy. 173
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 172
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 172
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 172
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 172
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 171
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 171
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 171
The Clinical Significance of Unknown Sequence Variants in BRCA Genes 169
A headlight on liquid biopsies: a challenging tool for breast cancer management 168
THE ROLE OF PSYCHOLOGICAL ASPECTS IN ONCOGENETIC COUNSELLING 167
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 166
HER2-positive male breast cancer: An update 166
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 165
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 164
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies:a meta-analysis(1988-2007) 164
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 164
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 163
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 163
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 163
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 161
Anti-endothelin drugs in solid tumors 161
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 161
Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. 160
Targeted Therapies in Hepatocellular Carcinoma 160
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 160
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 159
Nintedanib in NSCLC: Evidence to date and place in therapy 159
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 158
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 158
Monoclonal antibodies in gastrointestinal cancers 158
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 157
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 156
Longevity: Lesson from model organisms 156
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 156
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 156
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 155
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 153
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 153
Breast cancer genome-wide association studies: there is strength in numbers 153
Biomarkers and efficacy: Are we nearly there yet? 153
Role of S128R polymorphism of E-selectin in colon metastasis formation 153
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 152
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 152
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma 152
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 152
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 151
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 151
Role of curcumin in idiopathic pulmonary arterial hypertension treatment: A new therapeutic possibility 151
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 151
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 151
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 150
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 150
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 150
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 149
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 149
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 149
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. 148
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis 148
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 148
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 147
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 147
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 147
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 147
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 146
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) 146
The role of targeted therapy for gastrointestinal tumors 146
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 145
Totale 17.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.573 0 0 0 0 0 0 0 0 0 0 1.325 1.248
2019/202015.721 1.434 673 1.052 2.445 1.734 1.878 1.520 1.124 1.377 859 1.223 402
2020/20217.962 504 543 613 799 733 342 749 550 830 837 721 741
2021/20226.719 388 1.380 245 250 293 279 409 357 660 773 613 1.072
2022/20238.874 905 1.695 169 927 937 1.218 495 638 1.327 66 350 147
2023/20243.333 182 523 271 334 278 743 486 323 45 118 30 0
Totale 54.822